MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first and only proven non-incisional permanent birth control method available, today announced that it has appointed John Bishop, 64, to its Board of Directors, effective February 24, 2009. With the addition of Mr. Bishop, the size of Conceptus’ board is increased to seven. Mr. Bishop is chief executive officer of Cepheid, Inc., a leading molecular diagnostics company based in Sunnyvale, Calif.
